comparemela.com

Page 8 - Nyse Nvo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

302 Shares in Novo Nordisk A/S (NYSE:NVO) Acquired by Kathleen S Wright Associates Inc

Kathleen S. Wright Associates Inc. bought a new position in Novo Nordisk A/S (NYSE:NVO – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 302 shares of the company’s stock, valued at approximately $31,000. A number of other hedge funds have also […]

Calamos Wealth Management LLC Acquires 1,222 Shares of Novo Nordisk A/S (NYSE:NVO)

Calamos Wealth Management LLC raised its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 2.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,573 shares of the company’s stock after acquiring an additional 1,222 shares during the […]

250 Shares in Novo Nordisk A/S (NYSE:NVO) Bought by CNB Bank

CNB Bank acquired a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 250 shares of the company’s stock, valued at approximately $26,000. Other large investors also recently bought and sold shares of the company. Pacific Center for Financial Services raised its position […]

Novo Nordisk A/S (NYSE:NVO) Trading Down 0 4%

Shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) traded down 0.4% during trading on Wednesday . The company traded as low as $121.79 and last traded at $123.45. 3,044,113 shares traded hands during trading, a decline of 15% from the average session volume of 3,581,832 shares. The stock had previously closed at $123.90. […]

Novo Nordisk A/S (NYSE:NVO) Now Covered by BMO Capital Markets

BMO Capital Markets assumed coverage on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research note released on Friday, MarketBeat.com reports. The firm issued an outperform rating and a $163.00 price target on the stock. A number of other equities analysts also recently commented on the company. Cantor Fitzgerald reiterated an overweight […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.